Cargando…
Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics
Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080912/ https://www.ncbi.nlm.nih.gov/pubmed/27075578 http://dx.doi.org/10.2174/1381612822666160414142547 |
_version_ | 1782462822145327104 |
---|---|
author | Fukunishi, Yoshifumi Mashimo, Tadaaki Misoo, Kiyotaka Wakabayashi, Yoshinori Miyaki, Toshiaki Ohta, Seiji Nakamura, Mayu Ikeda, Kazuyoshi |
author_facet | Fukunishi, Yoshifumi Mashimo, Tadaaki Misoo, Kiyotaka Wakabayashi, Yoshinori Miyaki, Toshiaki Ohta, Seiji Nakamura, Mayu Ikeda, Kazuyoshi |
author_sort | Fukunishi, Yoshifumi |
collection | PubMed |
description | Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design. |
format | Online Article Text |
id | pubmed-5080912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-50809122016-11-14 Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics Fukunishi, Yoshifumi Mashimo, Tadaaki Misoo, Kiyotaka Wakabayashi, Yoshinori Miyaki, Toshiaki Ohta, Seiji Nakamura, Mayu Ikeda, Kazuyoshi Curr Pharm Des Article Computer-aided drug design is still a state-of-the-art process in medicinal chemistry, and the main topics in this field have been extensively studied and well reviewed. These topics include compound databases, ligand-binding pocket prediction, protein-compound docking, virtual screening, target/off-target prediction, physical property prediction, molecular simulation and pharmacokinetics/pharmacodynamics (PK/PD) prediction. Message and Conclusion: However, there are also a number of secondary or miscellaneous topics that have been less well covered. For example, methods for synthesizing and predicting the synthetic accessibility (SA) of designed compounds are important in practical drug development, and hardware/software resources for performing the computations in computer-aided drug design are crucial. Cloud computing and general purpose graphics processing unit (GPGPU) computing have been used in virtual screening and molecular dynamics simulations. Not surprisingly, there is a growing demand for computer systems which combine these resources. In the present review, we summarize and discuss these various topics of drug design. Bentham Science Publishers 2016-07 2016-07 /pmc/articles/PMC5080912/ /pubmed/27075578 http://dx.doi.org/10.2174/1381612822666160414142547 Text en © 2016 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Fukunishi, Yoshifumi Mashimo, Tadaaki Misoo, Kiyotaka Wakabayashi, Yoshinori Miyaki, Toshiaki Ohta, Seiji Nakamura, Mayu Ikeda, Kazuyoshi Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title | Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title_full | Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title_fullStr | Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title_full_unstemmed | Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title_short | Miscellaneous Topics in Computer-Aided Drug Design: Synthetic Accessibility and GPU Computing, and Other Topics |
title_sort | miscellaneous topics in computer-aided drug design: synthetic accessibility and gpu computing, and other topics |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080912/ https://www.ncbi.nlm.nih.gov/pubmed/27075578 http://dx.doi.org/10.2174/1381612822666160414142547 |
work_keys_str_mv | AT fukunishiyoshifumi miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT mashimotadaaki miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT misookiyotaka miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT wakabayashiyoshinori miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT miyakitoshiaki miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT ohtaseiji miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT nakamuramayu miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics AT ikedakazuyoshi miscellaneoustopicsincomputeraideddrugdesignsyntheticaccessibilityandgpucomputingandothertopics |